Patients with CKD have deranged bone-mineral metabolism, with increased levels of the phosphaturic hormone fibroblast growth factor 23 (FGF-23) and parathyroid hormone (PTH) arising from impaired renal excretion of phosphate and impaired vitamin D activation [6]. This evidence concerns the gene FGF23 and chronic kidney disease.